NCT05029024

Brief Summary

Investigators conducted a parallel-group, non-blinded, randomised control trial at the haemato-oncology unit of University Malaya Medical Centre, from 1st October 2019 to 31st May 2020. Patients included were ≥ 18 years, had histopathological diagnosis of haematological cancer, and fatigue score of ≥ 4 based on the fatigue subscale of Edmonton Symptom Assessment System (ESAS). Patients allocated to the intervention group received standard care plus a guided 30-minute mindful breathing session, while those in control group received standard care. The study outcomes include fatigue severity according to the fatigue subscale of ESAS, visual analogue scale of 0 - 10, and Functional Assessment of Chronic Illness Therapy Fatigue Scale Version 4, at minute 0 and minute 30.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 4, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 31, 2021

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

8 months

First QC Date

August 4, 2021

Last Update Submit

August 15, 2021

Conditions

Keywords

Haematological cancerfatiguemindful breathingEdmonton Symptom Assessment System

Outcome Measures

Primary Outcomes (3)

  • Fatigue severity by Edmonton Symptom Assessment System

    Fatigue severity according to the tiredness subscale of Edmonton Symptom Assessment System. The scale range 0 (no tiredness) to 10 (worst possible tiredness). The higher the value indicates the more tiredness/fatigue.

    30-minute

  • Fatigue severity by unidimensional visual analogue scale

    Fatigue severity according to the unidimensional visual analogue scale. The analogue scale range 0 - 10, the higher indicates the worst fatigue.

    30-minute

  • Fatigue severity by Functional Assessment of Chronic Illness Therapy Fatigue Scale Version 4

    Fatigue severity according to the the score of Functional Assessment of Chronic Illness Therapy Fatigue Scale Version 4. This Scale has 13 items, each item range from 0 (not at all) to 4 (very much). The total score range from 0 to 52, the higher indicates more fatigue.

    30-minute

Secondary Outcomes (1)

  • General feedback

    30-minute

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

Patients allocated to the intervention group received standard care plus a guided 30-minute mindful breathing session which consisted of four breathing exercises done consecutively in one-to-one manner. The four exercises included identifying the in-and out-breath, following the entire length of the breath, bringing the mind back to the body and relaxing the whole body. Each exercise lasted 7.5 minutes. Guidance was given by one of the two research assistants, who were medical doctors. They were trained by one of the co-investigators, who was a palliative care physician, certified in mindfulness training.

Other: 30-minute mindful breathing

Control group

PLACEBO COMPARATOR

Patients in the control group received standard care alone.

Other: control group

Interventions

The four exercises included identifying the in-and out-breath, following the entire length of the breath, bringing the mind back to the body and relaxing the whole body. Each exercise lasted 7.5 minutes.

Intervention group

standard care alone

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years and above
  • had a histopathological diagnosis of haematological cancer according to World Health Organisation classification
  • a fatigue score of ≥ 4 based on the fatigue subscale of Edmonton Symptom Assessment System

You may not qualify if:

  • impaired conscious level
  • cognitive impairment or any psychiatric illness that would prevent patients from giving informed consent or participate fully in the study
  • active or past history of cancer of other systems
  • a haemoglobin level of \< 8g/dl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diana-Leh-Ching Ng

Kuala Lumpur, 50603, Malaysia

Location

Related Publications (1)

  • Ng DL, Gan GG, Anuar NA, Tung YZ, Lai NZ, Tan YW, Said SNM, Madihie A, Chai CS, Tan SB. The effect of a single session of 30-min mindful breathing in reducing fatigue among patients with haematological cancer - a randomised controlled trial. BMC Palliat Care. 2021 Oct 15;20(1):160. doi: 10.1186/s12904-021-00855-7.

MeSH Terms

Conditions

FatigueHematologic Neoplasms

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Seng-Beng Tan, MBBS

    Consultant, University Malaya Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel-group, non-blinded, randomised control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2021

First Posted

August 31, 2021

Study Start

October 1, 2019

Primary Completion

May 31, 2020

Study Completion

May 31, 2020

Last Updated

August 31, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations